Original Article
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020
Read
2417
Timeswas read the article
1003
Total PDF
1414
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 4 | 12 |
| 2025 5 | 88 | 61 | 149 |
| 2025 4 | 76 | 35 | 111 |
| 2025 3 | 62 | 37 | 99 |
| 2025 2 | 53 | 20 | 73 |
| 2025 1 | 50 | 37 | 87 |
| 2024 12 | 42 | 40 | 82 |
| 2024 11 | 52 | 40 | 92 |
| 2024 10 | 32 | 33 | 65 |
| 2024 9 | 42 | 29 | 71 |
| 2024 8 | 54 | 50 | 104 |
| 2024 7 | 47 | 32 | 79 |
| 2024 6 | 41 | 30 | 71 |
| 2024 5 | 35 | 35 | 70 |
| 2024 4 | 52 | 25 | 77 |
| 2024 3 | 37 | 26 | 63 |
| 2024 2 | 32 | 32 | 64 |
| 2024 1 | 33 | 32 | 65 |
| 2023 12 | 52 | 45 | 97 |
| 2023 11 | 62 | 62 | 124 |
| 2023 10 | 41 | 50 | 91 |
| 2023 9 | 65 | 51 | 116 |
| 2023 8 | 95 | 40 | 135 |
| 2023 7 | 114 | 37 | 151 |
| 2023 6 | 89 | 47 | 136 |
| 2023 5 | 38 | 44 | 82 |
| 2023 4 | 22 | 29 | 51 |
Show all
